Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schroeter

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
The American Journal of Pathology|September 26, 2003
CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destructionMichael Schroeter, Guido Stoll, Robert Weissert, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2004
Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophagesGuido Stoll, Michael Schroeter, Sebastian Jander, et al.
European Journal of Neurology|March 3, 2025
Successful Natalizumab Treatment of Two Female Individuals With Susac SyndromeAgni M Konitsioti, Rafael Grajewski, Mark Schlamann, et al.
Journal of Neurology|April 24, 2024
Rituximab in non-systemic vasculitic neuropathy: a single-center experienceFelix Kohle, Gilbert Wunderlich, Gereon R Fink, et al.
Laboratory Animals|December 15, 2025
Transcranial direct current stimulation (tDCS) in conscious mice: a refined method for repetitive applications without restraintNora Rautenberg, Stefan Johannes Blaschke, Susan Vlachakis, et al.
Stroke|August 25, 2007
Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic strokeAndreas Saleh, Michael Schroeter, Adrian Ringelstein, et al.
Frontiers in Neurology|May 15, 2026
Case Report: B-cell-targeted therapy with ofatumumab achieves remission in refractory panuveitis and coexisting multiple sclerosisAgni M Konitsioti, Jeany Q Lammert, Sabine Vay, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|February 24, 2018
Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controlsDesiree Willkommen, Marianna Lucio, Philippe Schmitt-Kopplin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2009
Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiformeNorbert Galldiks, Roland Ullrich, Michael Schroeter, et al.
Vascular Pharmacology|September 28, 2005
Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agentTimo Kahles, Christian Foerch, Matthias Sitzer, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
The American Journal of Pathology|September 26, 2003
CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destructionMichael Schroeter, Guido Stoll, Robert Weissert, et al.
Brain Pathology (Zurich, Switzerland)|March 5, 2004
Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophagesGuido Stoll, Michael Schroeter, Sebastian Jander, et al.
European Journal of Neurology|March 3, 2025
Successful Natalizumab Treatment of Two Female Individuals With Susac SyndromeAgni M Konitsioti, Rafael Grajewski, Mark Schlamann, et al.
Journal of Neurology|April 24, 2024
Rituximab in non-systemic vasculitic neuropathy: a single-center experienceFelix Kohle, Gilbert Wunderlich, Gereon R Fink, et al.
Laboratory Animals|December 15, 2025
Transcranial direct current stimulation (tDCS) in conscious mice: a refined method for repetitive applications without restraintNora Rautenberg, Stefan Johannes Blaschke, Susan Vlachakis, et al.
Stroke|August 25, 2007
Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic strokeAndreas Saleh, Michael Schroeter, Adrian Ringelstein, et al.
Frontiers in Neurology|May 15, 2026
Case Report: B-cell-targeted therapy with ofatumumab achieves remission in refractory panuveitis and coexisting multiple sclerosisAgni M Konitsioti, Jeany Q Lammert, Sabine Vay, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|February 24, 2018
Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controlsDesiree Willkommen, Marianna Lucio, Philippe Schmitt-Kopplin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2009
Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiformeNorbert Galldiks, Roland Ullrich, Michael Schroeter, et al.
Vascular Pharmacology|September 28, 2005
Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agentTimo Kahles, Christian Foerch, Matthias Sitzer, et al.
Pageof 13